CM
UTHR icon

Caption Management’s United Therapeutics UTHR Stock Holding History

Caption Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$199M Sell
366,600
-300,600
-45% -$169M 0.93% 14
2026
Q1 		$396M Buy
667,200
+444,400
+199% +$221M 2.31% 2
2025
Q4 		$109M Sell
222,800
-30,800
-12% -$14.3M 0.74% 23
2025
Q3 		$106M Buy
253,600
+203,500
+406% +$68.4M 0.83% 17
2025
Q2 		$14.4M Buy
50,100
+5,100
+11% +$1.52M 0.16% 131
2025
Q1 		$13.9M Buy
45,000
+25,000
+125% +$8.57M 0.13% 140
2024
Q4 		$7.06M Buy
+20,000
New +$7.35M 0.07% 272
2024
Q3 		– Sell
-34,000
Closed -$10.8M – 1598
2024
Q2 		$10.8M Buy
+34,000
New +$9M 0.17% 131
2023
Q4 		– Sell
-15,000
Closed -$3.39M – 1699
2023
Q3 		$3.39M Hold
15,000
– – 0.05% 438
2023
Q2 		$3.31M Buy
+15,000
New +$3.32M 0.06% 380
2022
Q4 		– Sell
-60,000
Closed -$12.6M – 1743
2022
Q3 		$12.6M Buy
60,000
+40,000
+200% +$8.94M 0.17% 121
2022
Q2 		$4.71M Buy
+20,000
New +$4.07M 0.07% 365
2022
Q1 		– Sell
-20,000
Closed -$4.32M – 1973
2021
Q4 		$4.32M Buy
+20,000
New +$3.93M 0.05% 500
2021
Q2 		– Sell
-15,000
Closed -$2.51M – 1586
2021
Q1 		$2.51M Buy
+15,000
New +$2.5M 0.05% 450
2019
Q4 		– Sell
-25,000
Closed -$1.99M – 1013
2019
Q3 		$1.99M Buy
+25,000
New +$2.01M 0.1% 238

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Caption Management's UTHR Position: Q2 2026 in Review

Caption Management reduced its United Therapeutics (UTHR) stake by 87% in Q2 2026, selling an estimated $36.7M and leaving 9,333 shares worth $5.06M. The position accounts for 0.02% of the portfolio, ranked #579.

Caption Management first reported a position in UTHR in Q3 2021 and has held it in 8 quarters since. The position peaked at $44.1M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Caption Management held 9,333 shares of United Therapeutics worth $5.06M as of Q2 2026.
  • Caption Management sold 65,112 United Therapeutics shares in Q2 2026, an estimated $36.7M.
  • United Therapeutics made up 0.02% of Caption Management's portfolio in Q2 2026, its #579 holding.
  • Caption Management first reported a position in United Therapeutics in Q3 2021 and has held it in 8 quarters since.
  • Caption Management's United Therapeutics position peaked at $44.1M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.